81 related articles for article (PubMed ID: 2465004)
21. Structural models of ribonuclease H domains in reverse transcriptases from retroviruses.
Nakamura H; Katayanagi K; Morikawa K; Ikehara M
Nucleic Acids Res; 1991 Apr; 19(8):1817-23. PubMed ID: 1709492
[TBL] [Abstract][Full Text] [Related]
22. Amino acid substitutions away from the RNase H catalytic site increase the thermal stability of Moloney murine leukemia virus reverse transcriptase through RNase H inactivation.
Konishi A; Hisayoshi T; Yokokawa K; Barrioluengo V; Menéndez-Arias L; Yasukawa K
Biochem Biophys Res Commun; 2014 Nov; 454(2):269-74. PubMed ID: 25450388
[TBL] [Abstract][Full Text] [Related]
23. Point mutations in conserved amino acid residues within the C-terminal domain of HIV-1 reverse transcriptase specifically repress RNase H function.
Schatz O; Cromme FV; Grüninger-Leitch F; Le Grice SF
FEBS Lett; 1989 Nov; 257(2):311-4. PubMed ID: 2479577
[TBL] [Abstract][Full Text] [Related]
24. Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase.
Julias JG; Ferris AL; Boyer PL; Hughes SH
J Virol; 2001 Jul; 75(14):6537-46. PubMed ID: 11413321
[TBL] [Abstract][Full Text] [Related]
25. Redesignation of the RNase D activity associated with retroviral reverse transcriptase as RNase H.
Hostomsky Z; Hughes SH; Goff SP; Le Grice SF
J Virol; 1994 Mar; 68(3):1970-1. PubMed ID: 7509004
[TBL] [Abstract][Full Text] [Related]
26. Linker insertion mutagenesis of the human immunodeficiency virus reverse transcriptase expressed in bacteria: definition of the minimal polymerase domain.
Prasad VR; Goff SP
Proc Natl Acad Sci U S A; 1989 May; 86(9):3104-8. PubMed ID: 2470090
[TBL] [Abstract][Full Text] [Related]
27. Ribonuclease H(70) from Saccharomyces cerevisiae possesses cryptic reverse transcriptase activity.
Karwan R; Kühne C; Wintersberger U
Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5919-23. PubMed ID: 2426707
[TBL] [Abstract][Full Text] [Related]
28. RNase H cleavage of tRNAPro mediated by M-MuLV and HIV-1 reverse transcriptases.
Smith CM; Potts WB; Smith JS; Roth MJ
Virology; 1997 Mar; 229(2):437-46. PubMed ID: 9126256
[TBL] [Abstract][Full Text] [Related]
29. Expression in Escherichia coli of a Moloney murine leukemia virus reverse transcriptase whose structure closely resembles the viral enzyme.
Hizi A; Hughes SH
Gene; 1988 Jun; 66(2):319-23. PubMed ID: 2458989
[TBL] [Abstract][Full Text] [Related]
30. Folding the ribonuclease H domain of Moloney murine leukemia virus reverse transcriptase requires metal binding or a short N-terminal extension.
Goedken ER; Marqusee S
Proteins; 1998 Oct; 33(1):135-43. PubMed ID: 9741851
[TBL] [Abstract][Full Text] [Related]
31. Analysis of retroviral pol gene products with antisera raised against fusion proteins produced in Escherichia coli.
Tanese N; Roth MJ; Goff SP
J Virol; 1986 Aug; 59(2):328-40. PubMed ID: 2426463
[TBL] [Abstract][Full Text] [Related]
32. RNase H activity is required for high-frequency repeat deletion during Moloney murine leukemia virus replication.
Brincat JL; Pfeiffer JK; Telesnitsky A
J Virol; 2002 Jan; 76(1):88-95. PubMed ID: 11739674
[TBL] [Abstract][Full Text] [Related]
33. Double-stranded RNA-dependent RNase activity associated with human immunodeficiency virus type 1 reverse transcriptase.
Ben-Artzi H; Zeelon E; Gorecki M; Panet A
Proc Natl Acad Sci U S A; 1992 Feb; 89(3):927-31. PubMed ID: 1371014
[TBL] [Abstract][Full Text] [Related]
34. RNase H activity associated with bacterially expressed reverse transcriptase of human T-cell lymphotropic virus III/lymphadenopathy-associated virus.
Hansen J; Schulze T; Moelling K
J Biol Chem; 1987 Sep; 262(26):12393-6. PubMed ID: 2442162
[TBL] [Abstract][Full Text] [Related]
35. Substitution of Asp114 or Arg116 in the fingers domain of moloney murine leukemia virus reverse transcriptase affects interactions with the template-primer resulting in decreased processivity.
Gu J; Villanueva RA; Snyder CS; Roth MJ; Georgiadis MM
J Mol Biol; 2001 Jan; 305(2):341-59. PubMed ID: 11124910
[TBL] [Abstract][Full Text] [Related]
36. Cloning and overexpression of Moloney murine leukemia virus reverse transcriptase in Escherichia coli.
Kotewicz ML; D'Alessio JM; Driftmier KM; Blodgett KP; Gerard GF
Gene; 1985; 35(3):249-58. PubMed ID: 2412939
[TBL] [Abstract][Full Text] [Related]
37. Transdominant inhibition of Moloney murine leukemia virus proliferation by defective mutants of reverse transcriptase.
Shirasawa Y; Sato S; Osawa T; Hirashima A
J Biochem; 1996 Jun; 119(6):1070-5. PubMed ID: 8827439
[TBL] [Abstract][Full Text] [Related]
38. Cloning, expression, and purification of a catalytic fragment of Moloney murine leukemia virus reverse transcriptase: crystallization of nucleic acid complexes.
Sun D; Jessen S; Liu C; Liu X; Najmudin S; Georgiadis MM
Protein Sci; 1998 Jul; 7(7):1575-82. PubMed ID: 9684890
[TBL] [Abstract][Full Text] [Related]
39. Purification and characterization of murine retroviral reverse transcriptase expressed in Escherichia coli.
Roth MJ; Tanese N; Goff SP
J Biol Chem; 1985 Aug; 260(16):9326-35. PubMed ID: 2410413
[TBL] [Abstract][Full Text] [Related]
40. Differential inhibition of DNA polymerase and RNase H activities of the reverse transcriptase by phosphonoformate.
Margalith M; Falk H; Panet A
Mol Cell Biochem; 1982 Mar; 43(2):97-103. PubMed ID: 6178013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
